戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mine, lithium) to psychological (i.e., brief cognitive therapy).
2  cognitive therapy (thus, 71% did not accept cognitive therapy).
3  and comparable overall outcomes to standard cognitive therapy.
4 ternative for treatment is mindfulness-based cognitive therapy.
5 onths after treatment than mindfulness-based cognitive therapy.
6 ial rhythm therapy, and of mindfulness-based cognitive therapy.
7 f a mood disorder were more likely to accept cognitive therapy.
8  more rapid remission than augmentation with cognitive therapy.
9 ide if necessary; others received individual cognitive therapy.
10 ssion rates were 46% for medication, 40% for cognitive therapy.
11 iversity, where medications were superior to cognitive therapy.
12 s to treat pharmacologically, but respond to cognitive therapies.
13 .61 to -10.23]; 11 trials and 287 patients), cognitive therapy (-13.36 [-18.40 to -8.21]; six trials
14 herapy for PTSD, 3 months of standard weekly cognitive therapy, 3 months of weekly emotion-focused su
15 eks, response rates in medications (50%) and cognitive therapy (43%) groups were both superior to the
16 e, < or =9) were significantly greater after cognitive therapy (58%) and phenelzine (58%) than after
17                                    Intensive cognitive therapy achieved faster symptom reduction and
18 ly more side effects than those who received cognitive therapy alone.
19                               Phenelzine and cognitive therapy also reduced symptoms significantly mo
20      Cognitive reappraisal is fundamental to cognitive therapies and everyday emotion regulation.
21  Anxiety-related disorders can be treated by cognitive therapies and transcranial magnetic stimulatio
22 changes in the brain have been observed with cognitive therapy and certain forms of meditation and le
23 reating pain and depression in FMS by adding cognitive therapy and coping skills components to a comp
24 f the conceptual and practical components of cognitive therapy and highlights some of the empirical e
25  of the depression-specific psychotherapies, cognitive therapy and interpersonal therapy, is reviewed
26 rate for mindfulness and low-to-moderate for cognitive therapy and lifestyle interventions; however,
27    The authors compared the effectiveness of cognitive therapy and pharmacotherapy as second-step str
28 mization strata that permitted comparison of cognitive therapy and pharmacotherapy.
29                           The scores between cognitive therapy and phenelzine did not differ signific
30  versus any augmentation strategy (including cognitive therapy), and a medication switch strategy onl
31 d all treatment strategies, 3% accepted only cognitive therapy, and 26% accepted cognitive therapy (t
32 vational enhancement therapy, behavioral and cognitive therapy, and contingency management, will be c
33 PTSD treatment guideline recommends PE, CPT, cognitive therapy, and trauma-focused cognitive-behavior
34 step treatments: cognitive therapy versus no cognitive therapy, any switch strategy versus any augmen
35                            Mindfulness-based cognitive therapy appears efficacious as a treatment for
36  These findings support the efficacy of meta-cognitive therapy as a viable psychosocial intervention.
37                           Patients receiving cognitive therapy as compared with those receiving stand
38 nitive behavior therapy or mindfulness-based cognitive therapy at a traumatic stress clinic in Sydney
39 augmentation was more rapidly effective than cognitive therapy augmentation of citalopram, whereas sw
40 pression or anxiety, clinicians should offer cognitive therapy, BA, CBT, MBSR, or interpersonal thera
41 lysis of randomized clinical trials reported cognitive therapy, behavioral activation, problem-solvin
42                                              Cognitive therapy can be as effective as medications for
43                                              Cognitive therapy can be successful in promoting clinica
44                                              Cognitive therapy combined with ADM treatment enhances t
45  psychotherapy for atypical depression or of cognitive therapy compared with a monoamine oxidase inhi
46                            Mindfulness-based cognitive therapy compared with treatment as usual led t
47                            Mindfulness-based cognitive therapy comprised mindfulness exercises adapte
48 py condition and 50 in the mindfulness-based cognitive therapy condition.
49 low-up evaluation, patients who had received cognitive therapy continued to improve, while those in t
50                                              Cognitive therapy (CT) may reduce depressive relapse and
51                             A pilot study of cognitive therapy (CT) specifically designed to prevent
52 risk of relapse/recurrence after acute phase cognitive therapy (CT), a continuation phase model of th
53                                              Cognitive therapy (CT), often labeled as the generic ter
54  in controlled trials, 40% to 60% respond to cognitive therapy (CT).
55        Compared with the control conditions, cognitive therapy (d = - 0.95, 95% CI: -1.64 to - 0.27),
56  little more than a week was as effective as cognitive therapy delivered over 3 months.
57 ntive cognitive therapy or mindfulness-based cognitive therapy during and/or after antidepressant tap
58 to second-step treatment, those who received cognitive therapy (either alone or in combination with c
59 ivational interviewing, relaxation training, cognitive therapy, exposure, problem-solving skills trai
60 8 (50%) of 197 participants were assigned to cognitive therapy for command hallucinations + treatment
61 ther people were assigned in a 1: 1 ratio to cognitive therapy for command hallucinations + treatment
62 e voices compared with 22 (28%) of 79 in the cognitive therapy for command hallucinations + treatment
63 (RCT) evaluating whether one form of TF-CBT, cognitive therapy for PTSD (CT-PTSD), was effective for
64 and efficacy of a 7-day intensive version of cognitive therapy for PTSD and to investigate whether co
65                                              Cognitive therapy for PTSD delivered intensively over li
66                                    Intensive cognitive therapy for PTSD is a feasible and promising a
67 ) were randomly allocated to 7-day intensive cognitive therapy for PTSD, 3 months of standard weekly
68 nventory than those in the mindfulness-based cognitive therapy group (mean difference, 6.6; 95% CI, 0
69 e relative to those in the mindfulness-based cognitive therapy group (mean difference, 7.1; 95% CI, 1
70 rious adverse events: two in patients in the cognitive therapy group (one attempted overdose and one
71 ly greater proportion of members of the meta-cognitive therapy group demonstrated improvement compare
72 ed the efficacy of a 12-week manualized meta-cognitive therapy group intervention designed to enhance
73  total scores were consistently lower in the cognitive therapy group than in the treatment as usual g
74 cognitive therapy group, 77% of the standard cognitive therapy group, 43% of the supportive therapy g
75 atment/wait assessment, 73% of the intensive cognitive therapy group, 77% of the standard cognitive t
76                                              Cognitive therapy has an enduring effect that extends be
77  therapy for PTSD and to investigate whether cognitive therapy has specific treatment effects by comp
78                                              Cognitive therapy is a system of psychotherapy with a po
79                                              Cognitive therapy is an effective intervention for recen
80 gnitive restructuring intervention, based on cognitive therapy materials, reliably and selectively re
81  a critical window during which prophylactic cognitive therapy may benefit people at risk of schizoph
82                                              Cognitive therapy may offer an effective alternative to
83 or insomnia, especially stimulus control and cognitive therapy, may be a helpful adjunct to treatment
84                            Mindfulness-based cognitive therapy (MBCT) has been shown to reduce risk o
85 ought to determine whether mindfulness-based cognitive therapy (MBCT) reduces distress in men with ad
86 g (n = 85) were randomly assigned to receive cognitive therapy (n = 28), a self-help booklet based on
87 ognitive mechanisms behind mindfulness-based cognitive therapy (n = 50) for recurrent depression comp
88 e paroxetine (n = 120), placebo (n = 60), or cognitive therapy (n = 60).
89 ion [N=56] or buspirone [N=61]) or switch to cognitive therapy (N=36) or another antidepressant (N=86
90 ts to either augmentation of citalopram with cognitive therapy (N=65) or medication (N=117; either su
91  the cognitive theory of psychopathology and cognitive therapy of specific psychiatric disorders was
92                                              Cognitive therapy (often labeled generically as cognitiv
93 ffects of brief components of behavioral and cognitive therapies on different cognitive processes, us
94                      One treatment also adds cognitive therapy, one adds supportive-expressive psycho
95 who consented to random assignment to either cognitive therapy or alternative pharmacologic strategie
96 ized, controlled trial comparing acute-phase cognitive therapy or clinical management plus either phe
97 female) from 4 RCTs that compared preventive cognitive therapy or mindfulness-based cognitive therapy
98  otherwise randomly assigned to receive meta-cognitive therapy or supportive psychotherapy in a group
99 ng education, certain medications, exercise, cognitive therapy, or all 4 should be recommended.
100                          At follow-up, fewer cognitive therapy patients (3 [11%]) had PTSD compared w
101  psychiatric severity and the superiority of cognitive therapy plus GDC compared with supportive-expr
102 counseling plus group drug counseling (GDC), cognitive therapy plus GDC, supportive-expressive therap
103                                              Cognitive therapy plus standard treatment vs standard tr
104 als were randomly assigned to receive either cognitive therapy plus treatment as usual (n=37), or tre
105 muted block sizes of four or six, to receive cognitive therapy plus treatment as usual, or treatment
106  = 49) or usual care plus a 15-session group cognitive therapy prevention program (n = 45).
107  = 49) or usual care plus a 15-session group cognitive therapy prevention program (n = 45).
108                               A brief, group cognitive therapy prevention program can reduce the risk
109                                              Cognitive therapy produced greater personality change th
110 d at the level of a nonsignificant trend for cognitive therapy relative to placebo.
111 roxetine responders (P = .003) but not among cognitive therapy responders (P = .86).
112                                              Cognitive therapy responders at higher risk for relapse
113 ssion effectively, but there is less data on cognitive therapy's effects in this population.
114                                          The cognitive therapy scale showed no difference for nonspec
115                        Patients treated with cognitive therapy showed a clinically significant mean i
116                                              Cognitive therapy significantly reduced psychiatric symp
117 -i incorporated at least 3 of the following: cognitive therapy, stimulus control, sleep restriction,
118 two research teams studied mindfulness-based cognitive therapy, they showed trends toward improvement
119  there is only 1 placebo-controlled trial of cognitive therapy, this trial fills a gap in the literat
120 ted only cognitive therapy, and 26% accepted cognitive therapy (thus, 71% did not accept cognitive th
121                  We therefore tested our new cognitive therapy to challenge the perceived power of vo
122 ogramming can be part of developing a new VR cognitive therapy to help people reduce smoking.
123     The findings have implications for using cognitive therapy to reduce defeatist attitudes that may
124                                         Meta-cognitive therapy uses cognitive-behavioral principles a
125 ity of the following second-step treatments: cognitive therapy versus no cognitive therapy, any switc
126 ines (d = 0.69, 95% CI: 0.09 to 1.30), while cognitive therapy was associated also with post-treatmen
127 entation of citalopram, whereas switching to cognitive therapy was better tolerated than switching to
128                                              Cognitive therapy was compared with medication augmentat
129                We aimed to establish whether cognitive therapy was effective in reducing psychiatric
130                                              Cognitive therapy was more effective in reducing symptom
131                                Acceptance of cognitive therapy was primarily associated with sociodem
132  and general anxiety, intensive and standard cognitive therapy were superior to supportive therapy.
133 he treatment efforts to depend on preventive cognitive therapies, which stand to benefit from the tim
134 s by comparing intensive and standard weekly cognitive therapy with an equally credible alternative t
135                                         Meta-cognitive therapy yielded significantly greater improvem

 
Page Top